Given the importance of TOP1 inhibition in cancer therapy [13,69], the role of TDP1 in TOP1-DPCR has been extensively investigated in vitro and in cell cultures [32,70–72], but data on the vertebrate models are sparse [47,73,74]. The gene discussed is TDP1; the disease is cancer.